Characteristic
Nevirapine-based Regimens
N=232
Efavirenz-based Regimens
N=12
P-value
Male (%)
134 (57.8)
8 (66.7)
0.766*
Mean age (± SD)
36.04±7.9
35±11.l
0.389**
Single including widowed/divorced (%)
119 (44.8)
7 (58.3)
0.69
No career (dependent) (%)
47 (20.3)
3 (25)
0.715*
WHO Stage 4 (%)
103 (44.4)
6 (50)
0.933
Body weight (Kg), mean ± SD
54.44 ±9.9
62.38±13.6
0.04**
Baseline CD4 cell count (cells/mm3), median (IQR)
34 (14-100)
64 (8-108)
0.633**
Baseline log HIV RNA, median (IQR) (n=104)
5.4 (4.96-5.77)
5.68 (4.93-5.86)
0.545**
Treatment outcomes
Virologic success (%), overall
86.5
100
0.30*
Resistance to antiretroviral treatment (%)
6.5
0
1.00*
Tolerability (%), overall
79.3
93.9
0.076
Lost to follow up (%)
3.4
